Ayukawa H - Search Results

1

Hearing loss due to aging (presbycusis).

Katsarkas A, Ayukawa H. Katsarkas A, et al. Among authors: ayukawa h. J Otolaryngol. 1986 Aug;15(4):239-44. J Otolaryngol. 1986. PMID: 3747020

2

Otitis media and hearing loss among 12-16-year-old Inuit of Inukjuak, Quebec, Canada.

Ayukawa H, Bruneau S, Proulx JF, Macarthur J, Baxter J. Ayukawa H, et al. Int J Circumpolar Health. 2004;63 Suppl 2:312-4. doi: 10.3402/ijch.v63i0.17926. Int J Circumpolar Health. 2004. PMID: 15736675 Free article.

3

Hearing screening outcomes in Inuit children in Nunavik, Quebec, Canada.

Ayukawa H, Lejeune P, Proulx JF. Ayukawa H, et al. Int J Circumpolar Health. 2004;63 Suppl 2:309-11. doi: 10.3402/ijch.v63i0.17925. Int J Circumpolar Health. 2004. PMID: 15736674 Free article.

4

Longitudinal observations (1987-1997) on the prevalence of middle ear disease and associated risk factors among Inuit children of Inukjuak, Nunavik, Quebec, Canada.

Bruneau S, Ayukawa H, Proulx JF, Baxter JD, Kost K. Bruneau S, et al. Among authors: ayukawa h. Int J Circumpolar Health. 2001 Nov;60(4):632-9. Int J Circumpolar Health. 2001. PMID: 11768445

5

Prevalence of middle ear abnormalities from otitis media in relation with pneumococcal vaccine use in the Inuit population of Nunavik, province of Quebec, Canada.

Le Meur JB, Ayukawa H, Proulx JF, De Wals P. Le Meur JB, et al. Among authors: ayukawa h. Vaccine. 2018 Aug 16;36(34):5180-5186. doi: 10.1016/j.vaccine.2018.07.008. Epub 2018 Jul 17. Vaccine. 2018. PMID: 30026032 Free article.

6

Middle ear abnormalities at age 5 years in relation with early onset otitis media and number of episodes, in the Inuit population of Nunavik, Quebec, Canada.

De Wals P, Lemeur JB, Ayukawa H, Proulx JF. De Wals P, et al. Among authors: ayukawa h. Int J Circumpolar Health. 2019 Dec;78(1):1599269. doi: 10.1080/22423982.2019.1599269. Int J Circumpolar Health. 2019. PMID: 30924406 Free PMC article.

7

The Benefits of Sound Field Amplification in Classrooms of Inuit Students of Nunavik: A Pilot Project.

Eriks-Brophy A, Ayukawa H. Eriks-Brophy A, et al. Among authors: ayukawa h. Lang Speech Hear Serv Sch. 2000 Oct 1;31(4):324-335. doi: 10.1044/0161-1461.3104.324. Lang Speech Hear Serv Sch. 2000. PMID: 27764470

8

Effect of UGT1A1, CYP3A and CES Activities on the Pharmacokinetics of Irinotecan and its Metabolites in Patients with UGT1A1 Gene Polymorphisms.

Yokokawa A, Kaneko S, Endo S, Minowa Y, Ayukawa H, Hirano R, Nagashima F, Naruge D, Okano N, Kobayashi T, Kawai K, Furuse J, Furuta T, Shibasaki H. Yokokawa A, et al. Among authors: ayukawa h. Eur J Drug Metab Pharmacokinet. 2021 Mar;46(2):317-324. doi: 10.1007/s13318-021-00675-3. Epub 2021 Feb 23. Eur J Drug Metab Pharmacokinet. 2021. PMID: 33619631

9

Biopsy-proven Loeffler endocarditis successfully treated with steroids.

Inoue T, Watanabe C, Ayukawa H, Nadahama T, Hosokawa A, Beppu K, Oya H, Sasaki Y, Takeda S, Shirasaka A, Doi T, Hashimoto T, Kawai C. Inoue T, et al. Among authors: ayukawa h. Circulation. 2015 Feb 24;131(8):e353-4. doi: 10.1161/CIRCULATIONAHA.114.012976. Circulation. 2015. PMID: 25712061 No abstract available.

10

A case of hypertrophic cardiomyopathy with mid-ventricular obstruction (MVO) -- dramatic long-term improvement with a DDD pacemaker as assessed by diastolic paradoxical jet flow velocity.

Sasaki Y, Inoue T, Beppu H, Shirasawa K, Kida Y, Takeda S, Ayukawa H, Shirasaka A, Kakio T, Doi T, Hashimoto T, Kawai C. Sasaki Y, et al. Among authors: ayukawa h. Int J Cardiol. 2011 Jul 15;150(2):217-9. doi: 10.1016/j.ijcard.2011.05.011. Epub 2011 Jun 12. Int J Cardiol. 2011. PMID: 21663981 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters